Literature DB >> 11083100

p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.

S P Hussain1, M H Hollstein, C C Harris.   

Abstract

The molecular archaeology of the mutation spectra of tumor suppressor genes generates hypotheses concerning the etiology and molecular pathogenesis of human cancer. The spectrum of somatic mutations in the p53 gene implicates environmental carcinogens and both endogenous agents and processes in the etiology of human cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083100     DOI: 10.1111/j.1749-6632.2000.tb06870.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  22 in total

1.  Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.

Authors:  Theodore M Brasky; Matthew R Bonner; Kirsten B Moysich; Christine B Ambrosone; Jing Nie; Meng Hua Tao; Stephen B Edge; Bhaskar V S Kallakury; Catalin Marian; David S Goerlitz; Maurizio Trevisan; Peter G Shields; Jo L Freudenheim
Journal:  Cancer Causes Control       Date:  2011-04-23       Impact factor: 2.506

Review 2.  An evolutionary paradigm for carcinogenesis?

Authors:  P Vineis; G Matullo; M Manuguerra
Journal:  J Epidemiol Community Health       Date:  2003-02       Impact factor: 3.710

3.  p53 Arg72Pro polymorphism and risk of basal cell carcinoma: a meta analysis.

Authors:  Yanli Tian; Li Li; Rongya Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Effects of hepatitis B virus on p53 expression in hepatoma cell line SMMU-7721.

Authors:  Jian-Hui Qu; Ming-Hua Zhu; Jing Lin; Can-Rong Ni; Fang-Mei Li; Zhi Zhu; Guan-Zhen Yu
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

Review 5.  Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

6.  An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer.

Authors:  Bríd M Ryan; Roger K Wolff; Nicola Valeri; Mohammed Khan; Dillon Robinson; Alessio Paone; Elise D Bowman; Abbie Lundgreen; Bette Caan; John Potter; Derek Brown; Carlo Croce; Martha L Slattery; Curtis C Harris
Journal:  Cancer Epidemiol       Date:  2014-08-15       Impact factor: 2.984

7.  Enthalpy-entropy contribution to carcinogen-induced DNA conformational heterogeneity.

Authors:  Fengting Liang; Bongsup P Cho
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

8.  Kinetics of O(6)-pyridyloxobutyl-2'-deoxyguanosine repair by human O(6)-alkylguanine DNA alkyltransferase.

Authors:  Delshanee Kotandeniya; Daniel Murphy; Shuo Yan; Soobong Park; Uthpala Seneviratne; Joseph S Koopmeiners; Anthony Pegg; Sreenivas Kanugula; Fekadu Kassie; Natalia Tretyakova
Journal:  Biochemistry       Date:  2013-05-31       Impact factor: 3.162

Review 9.  p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Authors:  Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

10.  Adiposity is associated with p53 gene mutations in breast cancer.

Authors:  Heather M Ochs-Balcom; Catalin Marian; Jing Nie; Theodore M Brasky; David S Goerlitz; Maurizio Trevisan; Stephen B Edge; Janet Winston; Deborah L Berry; Bhaskar V Kallakury; Jo L Freudenheim; Peter G Shields
Journal:  Breast Cancer Res Treat       Date:  2015-09-12       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.